Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Linzess
Linzess
Ironwood's Bowel Drug Sales Disappoint
TheStreet.com
Tue, 04/23/13 - 10:47 am
Ironwood
Linzess
Forest Labs
irritable bowel syndrome
IBS
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Ironwood Pharma posts 3Q profit on drug approval
Yahoo/AP
Wed, 10/17/12 - 11:29 am
Ironwood Pharmaceuticals
earnings
Linzess
Ironwood: FDA Approval Makes the Price Right for This Pharma Stock
Motley Fool
Tue, 09/11/12 - 01:19 pm
Ironwood
FDA
Linzess
FDA approves Ironwood, Forest Labs bowel drug
Yahoo/AP
Fri, 08/31/12 - 12:58 pm
FDA
Ironwood
Forest Labs
Linzess
Pages
« first
‹ previous
1
2